48,830
edits
m (w) |
(+Li-Fraumeni variant) |
||
Line 1: | Line 1: | ||
'''Li-Fraumeni syndrome''' is due to germline mutations in the gene TP53 (p53),<ref>{{OMIM|191170}}</ref> an important regulator of [[apoptosis]] and the cell cycle, i.e. cell division. It is implicated in a very large number of sporadic cancer. | '''Li-Fraumeni syndrome''' is due to germline mutations in the gene TP53 (p53),<ref name=omim191170>{{OMIM|191170}}</ref> an important regulator of [[apoptosis]] and the cell cycle, i.e. cell division. It is implicated in a very large number of sporadic cancer. | ||
Individuals with Li-Fraumeni syndrome are predisposed to cancer. TP53 is considered to be a tumour suppressor and like most tumour suppressors, inheritance is autosomal dominant. | Individuals with Li-Fraumeni syndrome are predisposed to cancer. TP53 is considered to be a tumour suppressor and like most tumour suppressors, inheritance is autosomal dominant. | ||
Line 12: | Line 12: | ||
*Acute [[leukemia]].<ref name=emed987356ov/> | *Acute [[leukemia]].<ref name=emed987356ov/> | ||
*[[Soft tissue lesions|Soft tissue sarcomas]].<ref name=emed987356ov/> | *[[Soft tissue lesions|Soft tissue sarcomas]].<ref name=emed987356ov/> | ||
==Li-Fraumeni variant== | |||
A germline mutation in CHEK2<ref name=omim604373>{{OMIM|604373}}</ref> is considered to a '''Li-Fraumeni variant''', as it interacts with TP53 and BRCA1. | |||
CHEK2 mutation are most strongly associated with [[breast cancer]] and [[colon cancer]]; thus, it is also known as | |||
hereditary breast & colorectal cancer (HBCC).<ref name=omim604373/> In addition to breast and colon cancers, it has also been associated with prostate and thyroid cancer.<ref>{{Ref PCPBoD8|545}}</ref> | |||
Memory device for ''CHEK2'' - two common cancers above and below the diaphragm: | |||
*Breast. | |||
*Thyroid. | |||
*Colon. | |||
*Kidney. | |||
==See also== | ==See also== |
edits